Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024

Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University Hospital, posted on X:

“Thanks to The European Society for Medical Oncology for the Merit Travel Grant to present our RWE study of ovarian cancer patients treated with PARP inhibitors in Spain, a young oncologist collaborative research, in ESMO Gynaecological Cancers Congress 2024.”

Source: Rodrigo Sánchez-Bayona/X